Literature DB >> 18040760

Velocity distribution and shear rate variability resulting from changes in the impeller location in the USP dissolution testing apparatus II.

Ge Bai1, Piero M Armenante.   

Abstract

PURPOSE: The United States Pharmacopoeia (USP) imposes strict requirements on the geometry and operating conditions of the USP Dissolution Testing Apparatus II. A previously validated Computational Fluid Dynamics (CFD) approach was used here to study the hydrodynamics of USP Apparatus II when the impeller was placed at four different locations, all within the limits specified by USP.
METHOD: CFD was used to predict the velocity profiles, energy dissipation rates, and strain rates when the impeller was placed in the reference location (centrally mounted, 25 mm off the vessel bottom), 2 mm off-center, 2 mm higher, and 2 mm lower than the reference location.
RESULTS: Small changes in impeller location, especially if associated with loss of symmetry, produced extensive changes in velocity profiles and shear rates. Centrally located impellers, irrespective of their off-bottom clearance, produced non-uniform but nearly symmetric strain rates. The off-center impeller produced a more uniform but slightly asymmetric strain rate distribution.
CONCLUSIONS: The system hydrodynamics depends strongly on small differences in equipment configurations and operating conditions, which are likely to affect significantly the flow field and shear rate experienced by the oral dosage form being tested, and hence the solid-liquid mass transfer and dissolution rate.

Entities:  

Mesh:

Year:  2007        PMID: 18040760     DOI: 10.1007/s11095-007-9477-z

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  13 in total

1.  Cause of high variability in drug dissolution testing and its impact on setting tolerances.

Authors:  S A Qureshi; J Shabnam
Journal:  Eur J Pharm Sci       Date:  2001-01       Impact factor: 4.384

2.  Simulating the hydrodynamic conditions in the United States Pharmacopeia paddle dissolution apparatus.

Authors:  Leonard G McCarthy; Carolin Kosiol; Anne Marie Healy; Geoff Bradley; James C Sexton; Owen I Corrigan
Journal:  AAPS PharmSciTech       Date:  2003       Impact factor: 3.246

Review 3.  Engineering tools for understanding the hydrodynamics of dissolution tests.

Authors:  Joseph Kukura; Paulo E Arratia; Edit S Szalai; Fernando J Muzzio
Journal:  Drug Dev Ind Pharm       Date:  2003-02       Impact factor: 3.225

4.  Hydrodynamics-induced variability in the USP apparatus II dissolution test.

Authors:  Jennifer L Baxter; Joseph Kukura; Fernando J Muzzio
Journal:  Int J Pharm       Date:  2005-03-23       Impact factor: 5.875

5.  Computational fluid dynamics modeling of the paddle dissolution apparatus: agitation rate, mixing patterns, and fluid velocities.

Authors:  Leonard G McCarthy; Geoff Bradley; James C Sexton; Owen I Corrigan; Anne Marie Healy
Journal:  AAPS PharmSciTech       Date:  2004-04-08       Impact factor: 3.246

6.  Hydrodynamic investigation of USP dissolution test apparatus II.

Authors:  Ge Bai; Piero M Armenante; Russell V Plank; Michael Gentzler; Kenneth Ford; Paul Harmon
Journal:  J Pharm Sci       Date:  2007-09       Impact factor: 3.534

7.  Experimental and computational determination of blend time in USP Dissolution Testing Apparatus II.

Authors:  Ge Bai; Piero M Armenante; Russell V Plank
Journal:  J Pharm Sci       Date:  2007-11       Impact factor: 3.534

Review 8.  The development of USP dissolution and drug release standards.

Authors:  J L Cohen; B B Hubert; L J Leeson; C T Rhodes; J R Robinson; T J Roseman; E Shefter
Journal:  Pharm Res       Date:  1990-10       Impact factor: 4.200

9.  Typical variability in drug dissolution testing: study with USP and FDA calibrator tablets and a marketed drug (glibenclamide) product.

Authors:  S A Qureshi; I J McGilveray
Journal:  Eur J Pharm Sci       Date:  1999-02       Impact factor: 4.384

10.  Systematic error associated with apparatus 2 of the USP dissolution test III: limitations of calibrators and the USP suitability test.

Authors:  D C Cox; W B Furman; L K Thornton; T W Moore; E H Jefferson
Journal:  J Pharm Sci       Date:  1983-08       Impact factor: 3.534

View more
  2 in total

1.  Impact of Select Geometric and Operational Parameters on Hydrodynamics in Dissolution Apparatus 2 (Paddle Apparatus): A Design of Experiments Analysis Based on Computational Fluid Dynamics Simulations.

Authors:  Satish Perivilli; Steven Walfish; Erika Stippler; Mark R Liddell
Journal:  Pharm Res       Date:  2022-05-16       Impact factor: 4.580

2.  Justification of disintegration testing beyond current FDA criteria using in vitro and in silico models.

Authors:  Lukas Uebbing; Lukas Klumpp; Gregory K Webster; Raimar Löbenberg
Journal:  Drug Des Devel Ther       Date:  2017-04-11       Impact factor: 4.162

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.